% | $
Quotes you view appear here for quick access.

Delcath Systems, Inc. Message Board

  • tony_montello2003 tony_montello2003 Mar 8, 2013 4:41 PM Flag

    DCTH Vs. CLSN not apple to apple comparison, DCTH Chemostat already approved in EU, Australia, Uk

    DCTH already proven efficacy and increases the life by significant amount compared to the Control Arm in a extremely tough cancer, some patients in the Chemostat group living beyond 5 years. I have been loading the boat since $1.47 and keep on accumulating under $2.00. My DCTH 12 month target $25.00+ DCTH will be gobbled up by big pharma soon after FDA approval.

    Let it be written,
    Dr. Tony Montello is here till $20.00

    Sentiment: Strong Buy

4.25+0.33(+8.42%)Jul 29 4:00 PMEDT